Search Results
Search for other papers by Markus Eszlinger in
Google Scholar
PubMed
Search for other papers by Alexandra Stephenson in
Google Scholar
PubMed
Search for other papers by Shideh Mirhadi in
Google Scholar
PubMed
Search for other papers by Konrad Patyra in
Google Scholar
PubMed
Search for other papers by Michael F Moran in
Google Scholar
PubMed
Search for other papers by Moosa Khalil in
Google Scholar
PubMed
Department of Pediatrics, Turku University Hospital, Turku, Finland
Search for other papers by Jukka Kero in
Google Scholar
PubMed
Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada
Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Department of Medicine, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
a more severe hyperthyroid phenotype, consistent with the previously described generation (Supplementary Fig. 1C and G) ( 11 ). The higher PTC incidence in females ( Fig. 2 ) is consistent with the increased degree of affectedness of females in this
Institute of Pathology, University Hospital Halle (Saale), Halle (Saale), Germany
Search for other papers by Markus Eszlinger in
Google Scholar
PubMed
Search for other papers by Paul Stewardson in
Google Scholar
PubMed
Search for other papers by John B McIntyre in
Google Scholar
PubMed
Search for other papers by Adrian Box in
Google Scholar
PubMed
Search for other papers by Moosa Khalil in
Google Scholar
PubMed
Search for other papers by Martin Hyrcza in
Google Scholar
PubMed
Search for other papers by Konstantin Koro in
Google Scholar
PubMed
Search for other papers by Dean Ruether in
Google Scholar
PubMed
Search for other papers by Jiahui Wu in
Google Scholar
PubMed
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
high incidence of NTRK fusions ( 19 ). Also, patients with locally advanced tumors with a high incidence of NTRK fusions should be tested when considering neoadjuvant therapy before resection ( 19 ). This testing should be performed before or during
Department of Nuclear Medicine, The Fourth hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Search for other papers by Zhaoqi Zhang in
Google Scholar
PubMed
Search for other papers by Josef Yu in
Google Scholar
PubMed
Search for other papers by Eva Rainer in
Google Scholar
PubMed
Search for other papers by Lindsay Hargitai in
Google Scholar
PubMed
Search for other papers by Zewen Jiang in
Google Scholar
PubMed
Search for other papers by Georgios Karanikas in
Google Scholar
PubMed
Search for other papers by Tatjana Traub-Weidinger in
Google Scholar
PubMed
Search for other papers by Richard Crevenna in
Google Scholar
PubMed
Search for other papers by Marcus Hacker in
Google Scholar
PubMed
Search for other papers by Shuren Li in
Google Scholar
PubMed
constitutes one of the largest cohorts compared to previous studies, the sample size remains relatively small due to the low incidence of MTC and relatively long survival rate. Furthermore, in our present study, no comparison study between [ 18 F]F-DOPA PET